Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer

This publication has 19 references indexed in Scilit:

• One-year morbidity after sentinel node biopsy and breast surgery
  The Breast, 2005
• A Prospective Evaluation of Positron Emission Tomography Scanning, Sentinel Lymph Node Biopsy, and Standard Axillary Dissection for Axillary Staging in Patients with Early Stage Breast Cancer
  Annals of Surgical Oncology, 2004
• FDG-PET for axillary lymph node staging in primary breast cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 2004
• Prospective Multicenter Study of Axillary Nodal Staging by Positron Emission Tomography in Breast Cancer: A Report of the Staging Breast Cancer With PET Study Group
  Journal of Clinical Oncology, 2004
• Determinants of Diagnostic Performance Of [F-18]Fluorodeoxyglucose Positron Emission Tomography for Axillary Staging in Breast Cancer
  Annals of Surgery, 2002
• Systemic treatment after sentinel lymph node biopsy in breast cancer: who, what, and why?
  Journal of the American College of Surgeons, 2001
• Positron emission tomography in breast cancer: a clinicopathological correlation of results.
  The British Journal of Radiology, 1999
• Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
  New England Journal of Medicine, 1997
• Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
  Cancer, 1989